Chiba M et al. used endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) to quantify the S100P protein to discriminate between pancreatic adenocarcinoma (PCA) and benign pancreatic lesions (BPL). This evidence concerns the gene S100P and pancreatic adenocarcinoma.